Apellis Pharmaceuticals, Inc. (APLS)
23.49
+0.93
(+4.12%)
USD |
NASDAQ |
Feb 06, 16:00
23.47
-0.02
(-0.09%)
After-Hours: 20:00
Apellis Pharmaceuticals Cash and Short Term Investments (Quarterly) : 480.60M for Sept. 30, 2025
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Amneal Pharmaceuticals, Inc. | 235.98M |
| Alnylam Pharmaceuticals, Inc. | 2.725B |
| Amicus Therapeutics, Inc. | 263.84M |
| Ionis Pharmaceuticals, Inc. | 2.243B |
| Sarepta Therapeutics, Inc. | 850.99M |